Insider Transactions in Q2 2022 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,036
+0.56%
|
$14,504
$14.84 P/Share
|
|
Jun 06
2022
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
6,424
-15.9%
|
$122,056
$19.25 P/Share
|
|
Jun 02
2022
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+14.63%
|
-
|
|
Jun 02
2022
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.04%
|
-
|
|
Jun 02
2022
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.85%
|
-
|
|
Jun 02
2022
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.04%
|
-
|
|
Jun 02
2022
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+15.14%
|
-
|
|
Jun 02
2022
|
Daniel K Spiegelman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+29.95%
|
-
|
|
Jun 02
2022
|
Rashmi Kumar Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+24.22%
|
-
|
|
Jun 02
2022
|
Dennis Langer Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+13.92%
|
-
|
|
Apr 14
2022
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.95%
|
-
|
|
Apr 14
2022
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+14.62%
|
-
|
|
Apr 01
2022
|
Eric Santa Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,976
-2.52%
|
$74,400
$25.88 P/Share
|